Ali Mokhtar Mahmoud

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

ACS chemical neuroscience

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

Cancer research

Istituto di Chimica Biomolecolare Consiglio Nazionale delle Ricerche

Seconda Università degli Studi di Napoli (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto di Chimica Biomolecolare Consiglio Nazionale delle Ricerche

Italy

PhD student, Early Stage Researcher , Marie Skłodowska-Curie Fellow

Zewail City of Science and Technology - Zewail City Campus

Egypt

Research Assistant :: Centre for Aging and Associated Diseases

Cairo University

Egypt

Research asistant and Master student :: Biotechnology lab, Cairo University Research Park (CURP, FARP)

Education History

Seconda Università degli Studi di Napoli

Italy

PHD

Cairo University

Egypt

MSC :: Biochemistry

Cairo University Sep 14 2004 - Jul 03 2008

Egypt

BSC :: Biochemistry

Publications

Claudia Mugnaini, Antonella Brizzi, Marco Paolino, Enrico Scarselli, Riccardo Castelli, Modesto de Candia, Nicola Gambacorta, Nicolotti Orazio, Magdalena Kostrzewa, Poulami Kumar, Ali Mokhtar Mahmoud, Vittoria Borgonetti, Monica Iannotta, Andrea Morace, Nicoletta Galeotti, Sabatino Maione, Cosimo D Altomare, Alessia Ligresti, Federico Corelli
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS chemical neuroscience 15 (5) (2024)
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, Enrico Scarselli, Riccardo Castelli, Modesto de Candia, Nicola Gambacorta, Nicolotti Orazio, Magdalena Kostrzewa, Poulami Kumar, Ali Mokhtar Mahmoud, Vittoria Borgonetti, Monica Iannotta, Andrea Morace, Nicoletta Galeotti, Sabatino Maione, Cosimo D Altomare, Alessia Ligresti, Federico Corelli
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS chemical neuroscience (2024)
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, Enrico Scarselli, Riccardo Castelli, Modesto de Candia, Nicola Gambacorta, Nicolotti Orazio, Magdalena Kostrzewa, Poulami Kumar, Ali Mokhtar Mahmoud, Vittoria Borgonetti, Monica Iannotta, Andrea Morace, Nicoletta Galeotti, Sabatino Maione, Cosimo D Altomare, Alessia Ligresti, Federico Corelli
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS chemical neuroscience 15 (5) (2024)
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, Enrico Scarselli, Riccardo Castelli, Modesto de Candia, Nicola Gambacorta, Nicolotti Orazio, Magdalena Kostrzewa, Poulami Kumar, Ali Mokhtar Mahmoud, Vittoria Borgonetti, Monica Iannotta, Andrea Morace, Nicoletta Galeotti, Sabatino Maione, Cosimo D Altomare, Alessia Ligresti, Federico Corelli
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS chemical neuroscience 15 (5) (2024)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Magdalena Kostrzewa, Ali Mokhtar Mahmoud, Roberta Verde, Federica Scotto di Carlo, Fernando Gianfrancesco, Fabiana Piscitelli, Alessia Ligresti
Modulation of Endocannabinoid Tone in Osteoblastic Differentiation of MC3T3-E1 Cells and in Mouse Bone Tissue over Time. Cells 10 (5) (2021)
Sara Kebbi, Maria Letizia Ciavatta, Ali Mokhtar Mahmoud, Marianna Carbone, Alessia Ligresti, Ramdane Seghiri, Margherita Gavagnin
Sesquiterpene Lactones with the 12,8-Guaianolide Skeleton from Algerian Centaurea omphalotricha. Biomolecules 11 (7) (2021)
Marianna Cerasuolo, Federica Maccarinelli, Daniela Coltrini, Ali Mokhtar Mahmoud, Viviana Marolda, Gaia Cristina Ghedini, Sara Rezzola, Arianna Giacomini, Luca Triggiani, Magdalena Kostrzewa, Roberta Verde, Debora Paris, Dominique Melck, Marco Presta, Alessia Ligresti, Roberto Ronca
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer. Cancer research 80 (7) (2020)
Claudia Mugnaini, Magdalena Kostrzewa, Marta Bryk, Ali Mokhtar Mahmoud, Antonella Brizzi, Stefania Lamponi, Gianluca Giorgi, Francesca Ferlenghi, Federica Vacondio, Paola Maccioni, Giancarlo Colombo, Marco Mor, Katarzyna Starowicz, Vincenzo Di Marzo, Alessia Ligresti, Federico Corelli
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo. Journal of medicinal chemistry 63 (13) (2020)
Claudia Mugnaini, Magdalena Kostrzewa, Marta Bryk, Ali Mokhtar Mahmoud, Antonella Brizzi, Stefania Lamponi, Gianluca Giorgi, Francesca Ferlenghi, Federica Vacondio, Paola Maccioni, Giancarlo Colombo, Marco Mor, Katarzyna Starowicz, Vincenzo Di Marzo, Alessia Ligresti, Federico Corelli
Correction to Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo. Journal of medicinal chemistry 63 (19) (2020)
Asmaa Reda, Alaa Refaat, Ahmed A Abd-Rabou, Ali Mokhtar Mahmoud, Mohamed Adel, Salwa Sabet, Sameh Saad Ali
Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells. Scientific reports 9 (1) (2019)

Ali Mokhtar Mahmoud.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ali Mokhtar Mahmoud